pharmaceutical investing Zosano Announces Publication of Positive Data on Qtrypta’s™ Potential as an Acute Treatment for Patients with Difficult-to-Treat Migraines
pharmaceutical investing Zosano Pharma Enters Into Capital Equipment Lease Agreement With Trinity Capital Investment
Ni-Co Energy Reports 4.60 Metres at 0.59% Nickel at Kremer-2; Phase-One Drilling Advances Magmatic Sulphide Exploration Model